[Biotherapy of neuroendocrine tumours of the gastrointestinal tract and pancreas]

C.P. Hansen; U. Knigge

[Biotherapy of neuroendocrine tumours of the gastrointestinal tract and pancreas]

1 Citation (Scopus)

Abstract

Biotherapy of hormonal symptoms and tumour growth is a mainstay in the therapy of metastatic neuroendocrine tumours of the gastrointestinal tract and pancreas. Symptomatic relief can be achieved by somatostatin analogues and interferon, either alone or in combination. The effect on tumour growth is less convincing although a stabilization of disease is recorded in almost 50% of patients. Interferon treatment should mainly be considered for tumours with a low proliferation index
Udgivelsesdato: 2008/6/9

Original language	Danish
Journal	Ugeskrift for læger
Volume	170
Issue number	24
Pages (from-to)	2145-2148
Number of pages	3
ISSN	0041-5782
Publication status	Published - 2008

Cite this

@article{e84ee780987e11de8bc9000ea68e967b,

title = "[Biotherapy of neuroendocrine tumours of the gastrointestinal tract and pancreas]",

abstract = "Biotherapy of hormonal symptoms and tumour growth is a mainstay in the therapy of metastatic neuroendocrine tumours of the gastrointestinal tract and pancreas. Symptomatic relief can be achieved by somatostatin analogues and interferon, either alone or in combination. The effect on tumour growth is less convincing although a stabilization of disease is recorded in almost 50% of patients. Interferon treatment should mainly be considered for tumours with a low proliferation index Udgivelsesdato: 2008/6/9",

author = "C.P. Hansen and U. Knigge",

year = "2008",

language = "Dansk",

volume = "170",

pages = "2145--2148",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "24",

}

TY - JOUR

T1 - [Biotherapy of neuroendocrine tumours of the gastrointestinal tract and pancreas]

AU - Hansen, C.P.

AU - Knigge, U.

PY - 2008

Y1 - 2008

N2 - Biotherapy of hormonal symptoms and tumour growth is a mainstay in the therapy of metastatic neuroendocrine tumours of the gastrointestinal tract and pancreas. Symptomatic relief can be achieved by somatostatin analogues and interferon, either alone or in combination. The effect on tumour growth is less convincing although a stabilization of disease is recorded in almost 50% of patients. Interferon treatment should mainly be considered for tumours with a low proliferation index Udgivelsesdato: 2008/6/9

AB - Biotherapy of hormonal symptoms and tumour growth is a mainstay in the therapy of metastatic neuroendocrine tumours of the gastrointestinal tract and pancreas. Symptomatic relief can be achieved by somatostatin analogues and interferon, either alone or in combination. The effect on tumour growth is less convincing although a stabilization of disease is recorded in almost 50% of patients. Interferon treatment should mainly be considered for tumours with a low proliferation index Udgivelsesdato: 2008/6/9

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 170

SP - 2145

EP - 2148

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 24

ER -